AAP
TRIB

Ardsley Advisory Partners’s Trinity Biotech TRIB Stock Holding History

Ardsley Advisory Partners’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-350
Closed -$601K – 188
2015
Q3 		$601K Hold
350
– – 0.15% 79
2015
Q2 		$948K Buy
350
+117
+50% +$304K 0.12% 79
2015
Q1 		$674K Buy
233
+66
+40% +$183K 0.09% 105
2014
Q4 		$438K Buy
167
+34
+26% +$87.9K 0.07% 130
2014
Q3 		$365K Hold
133
– – 0.05% 140
2014
Q2 		$461K Buy
133
+50
+60% +$178K 0.06% 166
2014
Q1 		$303K Buy
83
+16
+24% +$62.9K 0.05% 183
2013
Q4 		$251K Sell
67
-16
-19% -$57.6K 0.03% 133
2013
Q3 		$272K Sell
83
-50
-38% -$146K 0.06% 105
2013
Q2 		$337K Buy
+133
New +$331K 0.07% 96

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Ardsley Advisory Partners's TRIB Position: Q4 2015 in Review

Ardsley Advisory Partners sold out of Trinity Biotech (TRIB) in Q4 2015, closing a stake of 350 shares — an estimated $601K sold.

Ardsley Advisory Partners first reported a position in TRIB in Q2 2013 and held it in 10 quarters. The position peaked at $948K in Q2 2015. 81 funds tracked by Wall St. Rank hold TRIB as of Q4 2015.

  • Ardsley Advisory Partners reported no remaining Trinity Biotech position as of Q4 2015 after selling out during the quarter.
  • Ardsley Advisory Partners sold 350 Trinity Biotech shares in Q4 2015, an estimated $601K.
  • Ardsley Advisory Partners first reported a position in Trinity Biotech in Q2 2013 and held it in 10 quarters.
  • Ardsley Advisory Partners's Trinity Biotech position peaked at $948K in Q2 2015.
  • 81 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2015.

Based on Ardsley Advisory Partners's 13F filing for Q4 2015, filed 16 Feb 2016.